Patent details

Basic Information

Publication number:

EP3311828

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171634462

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED VASOACTIVE INTESTINAL PEPTIDES

French Title of Invention:

PEPTIDES INTESTINAUX VASOACTIFS MODIFIÉS

German Title of Invention:

MODIFIZIERTE VASOAKTIVE DARMPEPTIDE

SPC Number:

Dates

Filing date:

16/08/2010

Grant date:

07/04/2021

EP Publication Date:

25/04/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/04/2021

EP B1 Publication Date:

07/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/08/2021

Expiration date:

16/08/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/03/2021

 

 

Name:

Phasebio Pharmaceuticals, Inc.

Address:

One Great Valley Parkway Suite 30, Malvern, Pennsylvania 19355, United States (US)

Inventor

1

Name:

SADEGHI, Homayoun

Address:

United States (US)

2

Name:

TURNER, Andrew

Address:

United States (US)

3

Name:

DAGHER, Suzanne

Address:

United States (US)

Priority

Priority Number:

234151 P

Priority Date:

14/08/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/24; A61P 9/00; A61P 9/12; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202114

Publication date:

07/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages